Overcome brain disorders with advanced neuroscience.
Location: South Korea, Seoul
Employees: 51-200
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | Daedeok Ve... | dvpdvp.com |
| - | SBI Invest... | sbik.co.kr |
Mentions in press and media 14
| Date | Title | Description |
| 31.10.2024 | Neurophet and Siemens Healthineers: A New Era in Medical Innovation in China | The landscape of medical technology is shifting. Two companies, Neurophet and Siemens Healthineers, are leading the charge in China. Their recent partnerships signal a new era of innovation, collaboration, and market expansion. Both compani... |
| 30.10.2024 | Neurophet partners with Beijing LADO Technology… Intends to establish Joint Venture in China | Neurophet enters into a strategic agreement with LADO to distribute Neurophet SCALE PET Improves the efficiency of market entry with expertise of medical device go-to-market process in China through the establishment of joint venture SEOUL,... |
| 19.10.2024 | Revolutionizing Alzheimer's Diagnosis: The Neurophet and AriBio Collaboration | In the realm of Alzheimer's disease, innovation is the lifeblood of hope. Neurophet, a South Korean AI company, is at the forefront of this revolution. Their recent partnership with AriBio, a biopharmaceutical firm, aims to reshape how we d... |
| 18.10.2024 | Neurophet to host Symposium featuring renowned expert in Alzheimer's disease treatment from the U.S. | - Invited Neurophet's scientific advisor Stephen Salloway, professor of Neurology at Brown Medical School as guest speaker - Shared latest insights on brain image analysis used for prescription of Alzheimer's disease treatments such as 'Leq... |
| 15.10.2024 | Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis' | - Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease - Collaborates leveraging Neurophet's medical image analysis technology and AriBio's clinical ... |
| 04.10.2024 | Indian mental health app Lissun takes on AI with $3M and more briefs | Photo: Pixabay/Pexels Mental health app Lissun bags $3M for AI integration Mental health platform Lissun in India has scored $2.5 million in a pre-Series A funding round led by RPSG Capital Ventures. With its fresh funds, the startup plans ... |
| 09.09.2024 | Neurophet-NTU Singapore, recognized for outstanding joint research | - Neurophet accelerates global expansion for research and partnership in AI-driven brain image analysis SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announc... |
| 27.07.2024 | The Future of Brain Health: Innovations and Leadership in Alzheimer's and Multiple Sclerosis Treatments | In the ever-evolving landscape of biotechnology, two companies are making waves in the treatment of chronic neurological diseases: Immunic, Inc. and Neurophet. Both are leveraging advanced technologies and seasoned leadership to tackle the ... |
| 25.07.2024 | Neurophet to launch total solution for AD treatments 'Neurophet AQUA AD' at AAIC 2024 | - Demonstrates Neurophet AQUA AD for AD treatments such as Leqembi and Kisunla - Introduces updated version of Neurophet SCALE PET with centiloid scale feature SEOUL, South Korea, July 25, 2024 /PRNewswire/ -- Neurophet, an artificial intel... |
| 25.07.2024 | Neurophet to launch total solution for AD treatments 'Neurophet AQUA AD' at AAIC 2024 | - Demonstrates Neurophet AQUA AD for AD treatments such as Leqembi and Kisunla - Introduces updated version of Neurophet SCALE PET with centiloid scale feature SEOUL, South Korea, July 25, 2024 /PRNewswire/ -- Neurophet, an artificial intel... |
Show more